Mitchell Vamos - Concepedia

Concepedia

Author

Mitchell Vamos

Sanford Burnham Prebys Medical Discovery Institute ORCID

Also Known As

M Vamos, Mitchell Vamos, Vamos, M., Vamos, Mitchell

32

Publications

1.2K

Citations

10

H-Index

36

Concepts

All Affiliations

Sanford Burnham Prebys Medical Discovery Institute Salk Institute for Biological Studies Discovery Institute

MV

About

Mitchell Vamos is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Natural Sciences	2	2	43
3	Biochemistry	2	2	43
4	Engineering	1	1	35
5	Biomolecular Engineering	1	1	35

Mitchell Vamos

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates Daniel F. Egan, Matthew G. H. Chun, Mitchell Vamos, Molecular Cell Cell AutophagyMitophagySignal TransductionSignaling PathwayAutophagy Kinase Ulk1	2015	704
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency Lars Pache, Míriam Santos Dutra, Adam M. Spivak, Cell Host & Microbe Viral LatencyHiv-1 TranscriptionHuman RetrovirusImmunologyAntiviral Therapy	2015	145
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer Huiyu Ren, Nicole A. Bakas, Mitchell Vamos, Journal of Medicinal Chemistry	2020	67
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma Katelyn E. McCabe, Karl Bacos, Dan Lü, Cell Death and Disease	2014	66
Small-Molecule IAP Antagonists Sensitize Cancer Cells to TRAIL-Induced Apoptosis: Roles of XIAP and cIAPs Darren Finlay, Mitchell Vamos, Marcos González‐López, Molecular Cancer Therapeutics Signal TransductionSignaling PathwayMedicineReceptor Tyrosine KinaseApoptosis	2013	51
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins Darren Finlay, Peter Teriete, Mitchell Vamos, F1000Research Family MembersApoptosis ProteinApoptosisImmunologyCell Death	2017	49
Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM Douglas J. Sheffler, Cody J. Wenthur, Joshua Andrew Bruner, Bioorganic & Medicinal Chemistry Letters G Protein-coupled ReceptorMedicineNam ProbeFunctional SelectivityReceptor (Biochemistry)	2012	39
2-Aminopyridines via Reaction of Pyridine <i>N</i>-Oxides and Activated Isocyanides Mitchell Vamos, Nicholas D. P. Cosford The Journal of Organic Chemistry EngineeringHeterocyclicActivated IsocyanidesOrganic ChemistryIsolable N-formylaminopyridine Intermediate	2014	35
Expedient Synthesis of Highly Potent Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Unique Selectivity for ML-IAP Mitchell Vamos, Kate Welsh, Darren Finlay, ACS Chemical Biology ApoptosisCell DeathUnique SelectivityPharmacotherapyTumor Biology	2013	32
Propellane as a conformational device for the stabilization of the β-lactone of salinosporamide A Mitchell Vamos, Yoshihisa Kobayashi Tetrahedron Bioorganic ChemistryBiochemistrySalinosporamide ANatural SciencesMolecular Biology	2009	11

Page 1